Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma
Abstract Background The molecular signaling events involving in high malignancy and poor prognosis of hepatocellular carcinoma (HCC) are extremely complicated. Blockade of currently known targets has not yet led to successful clinical outcome. More understanding about the regulatory mechanisms in HC...
Main Authors: | Bin Dai, Xuan Zhang, Runze Shang, Jianlin Wang, Xisheng Yang, Hong Zhang, Qi Liu, Desheng Wang, Lin Wang, Kefeng Dou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12964-018-0312-4 |
Similar Items
-
ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens
by: Kiyoshi Takagi, et al.
Published: (2018-03-01) -
Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells
by: Katharina Kolb, et al.
Published: (2020-12-01) -
Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway
by: Yongping Zhou, et al.
Published: (2020-06-01) -
SRSF3 functions as an oncogene in colorectal cancer by regulating the expression of ArhGAP30
by: Ji-Lin Wang, et al.
Published: (2020-04-01) -
Role of ARHGAP29 nucleotide variants in the etiology of non-syndromic cleft lip with or without cleft palate.
by: Justyna Dąbrowska, et al.
Published: (2020-06-01)